Tamarack Advisers

Latest statistics and disclosures from Tamarack Advisers's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Tamarack Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Tamarack Advisers

Tamarack Advisers holds 46 positions in its portfolio as reported in the September 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Lantheus Holdings Equity (LNTH) 8.6 $15M -16% 208k 70.33
Allscripts Healthcare Soluti Equity (MDRX) 6.1 $10M +24% 685k 15.23
Pacira Biosciences Equity (PCRX) 6.1 $10M +11% 195k 53.19
Perrigo Equity (PRGO) 5.3 $9.1M +27% 255k 35.66
Tenet Healthcare Corp Equity (THC) 5.3 $9.0M +9% 175k 51.58
Cerus Corp Equity (CERS) 5.1 $8.7M +21% 2.4M 3.60
Si-bone Equity (SIBN) 4.7 $8.0M -14% 460k 17.46
Angiodynamics Equity (ANGO) 3.9 $6.6M 325k 20.46
Phreesia Equity (PHR) 3.9 $6.6M +6% 260k 25.48
Biomarin Pharmaceutical Equity (BMRN) 3.5 $6.0M +136% 71k 84.77
Sanofi- Depository Receipt (SNY) 3.5 $5.9M +63% 155k 38.02
Streamline Health Solutions Equity (STRM) 3.4 $5.9M NEW 4.9M 1.19
Cigna Corp Equity (CI) 3.3 $5.5M -68% 20k 277.45
Viatris Equity (VTRS) 3.3 $5.5M +85% 650k 8.52

Setup an alert

Tamarack Advisers will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Bioventus Inc - A Equity (BVS) 3.1 $5.3M 750k 7.00
Collegium Pharmaceutical Equity (COLL) 2.8 $4.8M +200% 300k 16.02
Cvs Health Corp Equity (CVS) 2.8 $4.8M NEW 50k 95.38
Alkermes Equity (ALKS) 2.6 $4.5M NEW 200k 22.33
Jazz Pharmaceuticals Equity (JAZZ) 2.3 $4.0M +20% 30k 133.30
Docgo Equity (DCGO) 2.2 $3.7M +114% 375k 9.92
Turning Point Brands Equity (TPB) 2.1 $3.5M -13% 165k 21.23
Atricure Equity (ATRC) 1.5 $2.6M -32% 68k 39.10
Rigel Pharmaceuticals Equity (RIGL) 1.4 $2.4M 2.0M 1.18
Icu Medical Equity (ICUI) 1.3 $2.3M +15% 15k 150.60
Merck & Co Equity (MRK) 1.3 $2.2M -66% 25k 86.12
Molina Healthcare Equity (MOH) 1.2 $2.0M NEW 6.0k 329.83
Iqvia Holdings Equity (IQV) 1.1 $1.8M NEW 10k 181.10
Tactile Systems Technology I Equity (TCMD) 1.0 $1.8M +28% 225k 7.79
Plexus Corp Equity (PLXS) 1.0 $1.8M +233% 20k 87.55
Ascendis Pharma A/s - Depository Receipt (ASND) 0.9 $1.5M 15k 103.27
Fennec Pharmaceuticals Equity (FENC) 0.8 $1.4M NEW 175k 8.10
Radnet Equity (RDNT) 0.7 $1.2M +20% 60k 20.35
Iveric Bio Equity (ISEE) 0.5 $897k -75% 50k 17.94
Somalogic Equity (SLGC) 0.5 $870k -14% 300k 2.90
Bio-rad Laboratories-a Equity (BIO) 0.5 $834k NEW 2.0k 417.00
Envista Holdings Corp Equity (NVST) 0.5 $820k NEW 25k 32.80
Dermtech Equity (DMTK) 0.4 $693k +75% 175k 3.96
Bdx Us 10/21/22 P260 Listed Option Put Option 0.4 $680k NEW 200.00 3400.00
Maxcyte Equity (MXCT) 0.3 $534k NEW 82k 6.50
Caredx Equity (CDNA) 0.3 $426k 25k 17.04
Viewray Equity (VRAY) 0.2 $364k -75% 100k 3.64
Spy Us 10/03/22 P350 Listed Option Put Option 0.1 $125k NEW 2.5k 50.00
Terrascend Corp Equity (TRSSF) 0.1 $96k 75k 1.28
Tlt Us 11/18/22 C125 Listed Option Call Option 0.0 $76k +60% 4.0k 19.00
Vtrs Us 10/21/22 C12 Listed Option Call Option 0.0 $30k NEW 4.0k 7.50
Cm Life Sciences Ii -cw27 Warrant (SLGCW) 0.0 $9.0k 20k 0.45

Past Filings by Tamarack Advisers

SEC 13F filings are viewable for Tamarack Advisers going back to 2015

View all past filings